The DigIT Trial: The Effectiveness and Implementation of a Coached Digital Insomnia Treatment Program in a Regional Healthcare System.
DigIT
Path To Better Sleep + Virtual Coaching: The Effectiveness and Implementation of Internet-Based Self-Management Program for Insomnia in a Regional Healthcare System
1 other identifier
interventional
244
1 country
5
Brief Summary
The study will evaluate the effectiveness and implementation of a Virtual Coaching Intervention to enhance use of a digital intervention delivering cognitive behavioral therapy for insomnia (digital CBTi) at primarily rural VISN 1 facilities. The digital CBTi program was developed by VA specifically for Veterans. The Digital CBTi program contains the core elements of CBTi (sleep restriction, stimulus control, etc.) and matches the form of commercial digital CBTi programs, but is publicly available, currently in use in VA, and includes unique activities such as Veteran videos and various sleep diary options. A virtual coaching intervention, where a coach based in VA Connecticut will provide telephone coaching support to Veterans referred to Digital CBTi across VISN 1 sites, will increase engagement and adherence while fostering improved clinical outcomes. The investigators have hypothesized that Veterans randomized to Digital CBTi with Coaching will report greater improvement in insomnia severity and sleep parameters compared to Digital CBTi plus Contact (an enhanced treatment as usual control that provides an initial contact but NO coaching). The strategy used to implement Digital CBTi with Coaching will result in adequate Reach among Veterans (operationalized as 5 progressive levels of Veteran engagement in Digital CBTi) and Adoption among providers (2 progressive levels of provider engagement). A three-part formative evaluation of implementation (pre-implementation, active implementation, maintenance) consisting of interviews with Veterans, providers, and staff will optimize implementation in real time by tailoring implementation strategy elements to specific contexts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2023
Typical duration for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2022
CompletedFirst Posted
Study publicly available on registry
September 28, 2022
CompletedStudy Start
First participant enrolled
April 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFebruary 3, 2026
January 1, 2026
2.5 years
September 22, 2022
January 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Insomnia Severity Index (ISI)
The ISI is the standard for self-reported insomnia symptoms. The ISI is a 7-item questionnaire (5-point Likert scale, total score ranges from 0-28) providing a global measure of perceived insomnia severity. The ISI has adequate psychometric properties and has been validated against sleep diary and polysomnographic measures of sleep. Total score categories: 0-7 = No clinically significant insomnia 8-14 = Subthreshold insomnia 15-21 = Clinical insomnia (moderate severity) 22-28 = Clinical insomnia (severe)
change from baseline to 10 weeks
Insomnia Severity Index (ISI)
The ISI is the standard for self-reported insomnia symptoms. The ISI is a 7-item questionnaire (5-point Likert scale, total score ranges from 0-28) providing a global measure of perceived insomnia severity. The ISI has adequate psychometric properties and has been validated against sleep diary and polysomnographic measures of sleep. Total score categories: 0-7 = No clinically significant insomnia 8-14 = Subthreshold insomnia 15-21 = Clinical insomnia (moderate severity) 22-28 = Clinical insomnia (severe)
change from baseline to 6 months
Secondary Outcomes (6)
Sleep Onset Latency (SOL)
change from baseline to 10 weeks
Sleep Onset Latency (SOL)
change from baseline to 6 months
Sleep Efficiency (SE)
change from baseline to 10 weeks
Sleep Efficiency (SE)
change from baseline to 6 months
Wake After Sleep Onset (WASO)
change from baseline to 10 weeks
- +1 more secondary outcomes
Study Arms (2)
Digital CBTi with Coaching
EXPERIMENTALVirtual Coaching integrated with Digital CBTI. Includes initial enrollment contact, onboarding call, and two follow-up support calls. The coach will be available as resource for technical and other support.
Digital CBTi without Coaching (+ initial contact)
NO INTERVENTIONThe control will be an enhanced treatment as usual condition where participants will receive: 1) provider referral to Digital CBTi; 2) initial enrollment contact and 3) NO virtual coaching contacts. If subjects have a question or need technical support, they will be instructed to contact study staff for assistance.
Interventions
The core coaching components are motivational support, clinical health education, and technical support. The specific objectives are: support PTBS engagement, foster subsequent treatment adherence, ensure appropriate implementation of guidelines for Sleep Restriction Therapy and Stimulus Control, identify and triage PTBS candidates who are not appropriate or need more intensive treatments, and provide PTBS course technical support.
Eligibility Criteria
You may qualify if:
- Veterans who meet the ICSD-3 Insomnia disorder diagnostic criteria,
- have an interest in digital CBTi, and
- have basic technology literacy.
You may not qualify if:
- Nighttime or Rotating Shift Work within the last 6 Months,
- Disorders: Psychotic DO; Bipolar DO;
- Dementia;
- moderate Cognitive Impairment;
- Epilepsy;
- Seizure DO,
- Severe OSA: untreated or treatment non-adherence,
- Current Exposure Therapy for PTSD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut, 06516-2770, United States
Maine VA Medical Center, Augusta, ME
Augusta, Maine, 04330, United States
VA Central Western Massachusetts Healthcare System, Leeds, MA
Leeds, Massachusetts, 01053-9764, United States
Manchester VA Medical Center, Manchester, NH
Manchester, New Hampshire, 03104-7007, United States
White River Junction VA Medical Center, White River Junction, VT
White River Junction, Vermont, 05001-3833, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric Hermes, MD
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
- PRINCIPAL INVESTIGATOR
Christi S. Ulmer, PhD
Durham VA Medical Center, Durham, NC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2022
First Posted
September 28, 2022
Study Start
April 27, 2023
Primary Completion
October 31, 2025
Study Completion
December 31, 2025
Last Updated
February 3, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share